Pain and addiction: managing risk through comprehensive care

Area of Science:

• Pain Management
• Addiction Medicine
• Psychiatry

Background:

• Concurrent substance use disorders and pain present complex challenges in healthcare.
• Pain and addiction can be co-occurring conditions requiring integrated treatment.
• Controlled substances, particularly opioids, play a dual role as potential solutions or problems in pain management.

Purpose of the Study:

• To explore clinical decision-making when patients exhibit aberrant behaviors.
• To emphasize the importance of a clear exit strategy in opioid pharmacotherapy.
• To differentiate patient motives from problematic behaviors in the context of treatment.

Main Methods:

• Review of clinical challenges in managing patients with co-occurring pain and substance use disorders.
• Analysis of the role of controlled substances in pain management.
• Discussion on interpreting aberrant patient behavior within the doctor-patient relationship.

Main Results:

• Aberrant behavior requires careful interpretation, separating motive from action.
• Not all patients benefit from opioid pharmacotherapy; some improve upon discontinuation.
• An exit strategy is crucial for any pharmacotherapy plan.

Conclusions:

• A biopsychosocial approach is essential for treating co-occurring pain and addiction.
• Clinical decisions regarding controlled substances must be reasoned and individualized.
• Accurate interpretation of aberrant behavior, avoiding premature diagnostic labels, is key to effective patient care.